StockVS

MetLife, Inc. (MET) Análisis de acciones

Servicios Financieros

MetLife, Inc.

$83.27

$-0.79 (-0.94%)

Última actualización: 26 de mayo de 2026

Historial de Precios

Noticias Recientes

Noticias proporcionadas por fuentes de terceros. No es asesoramiento financiero.

Análisis

Descripción de la empresa

MetLife, Inc. operates as a global financial services entity specializing in insurance, annuities, employee benefits, and asset management across diverse international markets. The company functions within the Financial Services sector, specifically the Insurance - Life industry, positioning it as a primary provider of risk protection and wealth management solutions for individuals and corporations. With a market capitalization of $44.61B and annual revenue reaching $77.08B, the organization employs a workforce of 46,000 individuals to execute its extensive operational footprint. These valuation and revenue figures indicate that MetLife maintains a substantial scale in the capital markets, reflecting its capacity to underwrite significant policy blocks and manage large-scale asset pools relative to peers in the life insurance sub-sector.

Salud financiera

The company reported a revenue of $77.08B and net income of $3.17B for the trailing twelve months, with an EBITDA of $5.96B, highlighting a distinct gap between top-line generation and bottom-line profitability that underscores a cost structure heavily influenced by underwriting expenses and investment income fluctuations. While the EBITDA suggests operational cash generation before interest and taxes, the net income figure reveals the substantial impact of interest obligations and tax liabilities on the final earnings available to shareholders. The free cash flow stands at -$12,738,499,584, which indicates that the company is currently consuming cash rather than generating it, a characteristic common in insurance firms where capital is retained to support policyholder liabilities and regulatory reserve requirements. Analyzing the margins reveals a gross margin of 23.4%, an operating margin of 4.7%, and a profit margin of 4.4%, where the disparity between operating and profit margins reflects the significant financial costs associated with debt servicing and tax structures. The balance sheet presents a leveraged position with total debt of $65.35B against cash reserves of $25.63B, resulting in a debt-to-equity ratio of 225.97% that signifies high financial leverage typical of the insurance model. Despite the high debt load, the current ratio of 1.90 demonstrates adequate short-term liquidity, suggesting the company can cover its current liabilities nearly twice over with its current assets. Return on Equity stands at 12.0% while Return on Assets is 0.5%, indicating that management is generating strong returns relative to shareholder capital but faces a challenge in utilizing the massive asset base efficiently relative to the total assets employed.

Evaluación de valoración

The trailing P/E ratio is 14.37, while the forward P/E is 6.19, implying that the market expects a significant expansion in future earnings relative to current levels or that current earnings are depressed by temporary factors. The price-to-book ratio of 1.56 suggests that the market values the company at a premium of 56% over its tangible book value, reflecting confidence in the quality of its intangible assets such as brand reputation and existing policy blocks. Alternative valuation metrics like the price-to-sales ratio of 0.58 and the EV/EBITDA of 14.15 provide context, indicating that the stock trades at less than a dollar of sales per share while maintaining an enterprise value multiple that is moderate for a financial services firm. The 52-week high is $85.00 and the 52-week low is $65.21, meaning the current trading price sits in a range that requires calculation relative to the upper bound to determine the percentage discount or premium from the yearly peak. The beta value of 0.74 indicates that the stock exhibits lower volatility than the broader market, moving approximately 26% less than the market index on average during periods of fluctuation.

Growth & Income

Revenue growth year-over-year accelerated to 27.6%, whereas earnings growth declined by 34.2%, revealing that top-line expansion is not translating into proportional bottom-line growth at this specific reporting period. The dividend yield is 3.4% with a payout ratio of 47.7%, suggesting that the company distributes nearly half of its earnings as dividends, a practice that must be monitored closely given the recent contraction in earnings growth which could impact sustainability. Since the payout ratio is derived from net income rather than EBITDA, the decline in earnings growth presents a potential constraint on the ability to maintain the current dividend level without increasing the payout ratio beyond sustainable thresholds. The overall growth and income profile presents a dichotomy where significant revenue expansion coexists with a substantial decline in profitability, tempered by a generous but potentially pressured dividend yield.

Comparación con pares

MetLife, Inc. (MET) opera en la industria de Seguros - Vida. Así se compara con sus pares más cercanos por capitalización de mercado:

Empresa Ticker Cap. de Mercado Ratio P/E
MetLife, Inc. MET $53.58B 16.1
Manulife Financial Corporation MFC.TO $88.82B 15.3
Great-West Lifeco Inc. GWO.TO $71.39B 17.1
Manulife Financial Corporation MFC $64.39B 15.3

El ratio P/E promedio de la industria Seguros - Vida es 18.3x. MetLife, Inc. cotiza a un P/E de 16.1.

Este análisis es generado por IA solo con fines informativos y no constituye asesoramiento financiero. Los datos pueden estar retrasados o ser inexactos. Siempre realice su propia investigación y consulte a un asesor financiero calificado antes de tomar decisiones de inversión.

Acerca de MetLife, Inc.

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

La descripción de la empresa se muestra en inglés.

Visitar sitio web →

Estadísticas Clave

Capitalización
$53.58B
Ratio P/E
16.11
Máximo 52 Sem.
$85.29
Mínimo 52 Sem.
$67.33
Volumen Promedio
3.58M
Beta
0.78
Rendimiento Dividendo
2.85%

Datos proporcionados por Yahoo Finance a través de yfinance. Actualizado diariamente.

Información de la Empresa

Bolsa
NYSE
País
United States
Empleados
46,000